Systemic inflammation contributes to impairment of quality of life in chronic pancreatitis

[1]  M. Cesari,et al.  Retraction to Chronic Inflammation: Accelerator of Biological Aging. , 2017, The journals of gerontology. Series A, Biological sciences and medical sciences.

[2]  D. Gibson,et al.  Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines , 2018, Front. Immunol..

[3]  A. Wachholtz,et al.  Quality of life comparison between smokers and non-smokers with chronic pancreatitis. , 2018, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[4]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[5]  M. Cesari,et al.  Chronic Inflammation: Accelerator of Biological Aging , 2017, The journals of gerontology. Series A, Biological sciences and medical sciences.

[6]  G. Lesinski,et al.  Local and Systemic Expression of Immunomodulatory Factors in Chronic Pancreatitis , 2017, Pancreas.

[7]  F. Mortensen,et al.  Chronic Pancreatitis and Pancreatic Cancer Risk: A Systematic Review and Meta-analysis , 2017, The American Journal of Gastroenterology.

[8]  Michelle A. Anderson,et al.  Quality of Life in Chronic Pancreatitis is Determined by Constant Pain, Disability/Unemployment, Current Smoking, and Associated Co-Morbidities , 2017, The American Journal of Gastroenterology.

[9]  M. Boermeester,et al.  United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU) , 2017, United European gastroenterology journal.

[10]  K. Tashima,et al.  Body mass index, inflammatory biomarkers and neurocognitive impairment in HIV-infected persons , 2017, Psychology, health & medicine.

[11]  Jun Yu,et al.  C-X-C motif chemokine 10 in non-alcoholic steatohepatitis: role as a pro-inflammatory factor and clinical implication , 2016, Expert Reviews in Molecular Medicine.

[12]  J. Rosendahl,et al.  Chronic pancreatitis: Do serum biomarkers provide an association with an inflammageing phenotype? , 2016, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[13]  P. Maisonneuve,et al.  Deficiency of fat-soluble vitamins in chronic pancreatitis: A systematic review and meta-analysis. , 2015, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[14]  A. Chawla,et al.  Alternatively activated macrophages promote pancreatic fibrosis in chronic pancreatitis , 2015, Nature Communications.

[15]  B. Baune,et al.  Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: A systematic review of biomarker studies , 2014, Neuroscience & Biobehavioral Reviews.

[16]  F. Bendtsen,et al.  Mortality, cancer, and comorbidities associated with chronic pancreatitis: a Danish nationwide matched-cohort study. , 2014, Gastroenterology.

[17]  D. Brigstock,et al.  Regulation of pancreatic inflammation by connective tissue growth factor (CTGF/CCN2) , 2014, Immunology.

[18]  P. Milkiewicz,et al.  In patients with liver cirrhosis, proinflammatory interleukins correlate with health-related quality of life irrespective of minimal hepatic encephalopathy , 2013, European journal of gastroenterology & hepatology.

[19]  C. Graversen,et al.  Pharmacological pain management in chronic pancreatitis. , 2013, World journal of gastroenterology.

[20]  J. Niu,et al.  CXC chemokine IP-10: a key actor in liver disease? , 2013, Hepatology International.

[21]  A. Ochiai,et al.  Associations of interleukin-6 with vegetative but not affective depressive symptoms in terminally ill cancer patients , 2013, Supportive Care in Cancer.

[22]  B. Pützer,et al.  Senescence determines the fate of activated rat pancreatic stellate cells , 2012, Journal of cellular and molecular medicine.

[23]  A. Siriwardena,et al.  Antioxidant therapy does not reduce pain in patients with chronic pancreatitis: the ANTICIPATE study. , 2012, Gastroenterology.

[24]  P. Sachdev,et al.  The association between systemic inflammation and cognitive performance in the elderly: the Sydney Memory and Ageing Study , 2012, AGE.

[25]  H. Brodaty.  Sydney memory and ageing study , 2011, Alzheimer's & Dementia.

[26]  A. Newman,et al.  Inflammatory markers in population studies of aging , 2011, Ageing Research Reviews.

[27]  R. Wachter,et al.  Serum Levels of Interleukin-6 and Interleukin-10 in Relation to Depression Scores in Patients with Cardiovascular Risk Factors , 2011, Behavioral medicine.

[28]  P. Sebastiani,et al.  Identification of serum biomarkers for aging and anabolic response , 2011, Immunity & Ageing.

[29]  F. Fang,et al.  Health-related Quality of life in 640 head and neck cancer survivors after radiotherapy using EORTC QLQ-C30 and QLQ-H&N35 questionnaires , 2011, BMC Cancer.

[30]  F. Real,et al.  Adult pancreatic acinar cells dedifferentiate to an embryonic progenitor phenotype with concomitant activation of a senescence programme that is present in chronic pancreatitis , 2010, Gut.

[31]  D. Fine,et al.  The epidemiology and socioeconomic impact of chronic pancreatitis. , 2010, Best practice & research. Clinical gastroenterology.

[32]  N. Kiguchi,et al.  Macrophage inflammatory protein-1α mediates the development of neuropathic pain following peripheral nerve injury through interleukin-1β up-regulation , 2010, PAIN®.

[33]  J. Campisi,et al.  The senescence-associated secretory phenotype: the dark side of tumor suppression. , 2010, Annual review of pathology.

[34]  T. Shiomi,et al.  Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis , 2009, Respiratory research.

[35]  A. Ishizaka,et al.  Elevated CC Chemokine Level in Bronchoalveolar Lavage Fluid Is Predictive of a Poor Outcome of Idiopathic Pulmonary Fibrosis , 2009, Respiration.

[36]  M. H. Pollack,et al.  A detailed examination of cytokine abnormalities in Major Depressive Disorder , 2008, European Neuropsychopharmacology.

[37]  A. Dennison,et al.  Role of Inflammation in Pancreatic Carcinogenesis and the Implications for Future Therapy , 2005, Pancreatology.

[38]  P. Malfertheiner,et al.  Symptoms and Quality of Life in Chronic Pancreatitis Assessed by Structured Interview and the EORTC QLQ-C30 and QLQ-PAN26 , 2005, The American Journal of Gastroenterology.

[39]  A. Andrén-sandberg,et al.  Cigarette smoking accelerates progression of alcoholic chronic pancreatitis , 2005, Gut.

[40]  T. Kirkwood,et al.  Understanding the Odd Science of Aging , 2005, Cell.

[41]  E. von Stebut,et al.  Macrophage inflammatory protein-1. , 2004, The international journal of biochemistry & cell biology.

[42]  E. Hahn,et al.  Health‐related quality of life in chronic pancreatitis: a psychometric assessment , 2003, Scandinavian journal of gastroenterology.

[43]  Min Huang,et al.  IL-7 inhibits fibroblast TGF-β production and signaling in pulmonary fibrosis , 2002 .

[44]  Min Huang,et al.  IL-7 inhibits fibroblast TGF-beta production and signaling in pulmonary fibrosis. , 2002, The Journal of clinical investigation.

[45]  M. Avantaggiati,et al.  The International Journal of Biochemistry & Cell Biology , 2015 .